Japanese General Merchandise and Department Stores Stock News

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...

As Asian markets navigate a complex landscape marked by mixed economic indicators and evolving investor sentiment, the region's technology sector continues to capture attention with its potential for high growth. In this environment, identifying promising tech stocks involves looking for companies that demonstrate resilience and innovation amidst shifting global trends and local challenges.

As global markets exhibit mixed signals, with Japan facing monetary tightening and China experiencing an economic slowdown, investors are increasingly turning their attention to dividend stocks in Asia as a potential source of steady income amidst uncertainty. In such a dynamic environment, selecting dividend stocks that offer stable yields and have resilient business models can be crucial for enhancing portfolio performance.

Key Insights The considerable ownership by state or government in Tokyo Metro indicates that they collectively have a...

Money Forward (TSE:3994) just unveiled a governance reshuffle, with several long serving external directors set to retire under newly formalized term limit and age rules, alongside a fresh review of its management structure. See our latest analysis for Money Forward. The governance clean up comes after a tough stretch for investors, with the share price down sharply over the last quarter and a weaker one year total shareholder return signaling that momentum has been fading. Still, today's...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

HASEKO (TSE:1808) has had a great run on the share market with its stock up by a significant 20% over the last three...

HORIBA (TSE:6856) has been quietly building momentum, with the share price up around 16% over the past month and more than 80% over the past year. This has drawn fresh attention to its valuation. See our latest analysis for HORIBA. With the share price now around ¥15,980, HORIBA’s strong 30 day and year to date share price returns, alongside an impressive multi year total shareholder return, point to clear positive momentum as investors reassess its growth and risk profile. If HORIBA’s run...

JAC Recruitment Co., Ltd. ( TSE:2124 ) will increase its dividend from last year's comparable payment on the 30th of...

The board of Keikyu Corporation ( TSE:9006 ) has announced that it will pay a dividend of ¥23.00 per share on the 30th...

With a median price-to-sales (or "P/S") ratio of close to 0.9x in the Hospitality industry in Japan, you could be...

There wouldn't be many who think FUJIFILM Holdings Corporation's ( TSE:4901 ) price-to-earnings (or "P/E") ratio of 15x...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Aichi Tokei Denki Co., Ltd. ( TSE:7723 ) has announced that it will pay a dividend of ¥45.00 per share on the 26th of...

Mitsui Kinzoku Company, Limited ( TSE:5706 ) will increase its dividend from last year's comparable payment on the 30th...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Nippon Thompson Co., Ltd.'s ( TSE:6480 ) investors are due to receive a payment of ¥14.00 per share on 30th of June...

The board of Furukawa Co.,Ltd. ( TSE:5715 ) has announced that it will pay a dividend on the 30th of June, with...

Tokyu Fudosan Holdings Corporation's ( TSE:3289 ) dividend will be increasing from last year's payment of the same...

With a price-to-earnings (or "P/E") ratio of 25.2x Broadmedia Corporation ( TSE:4347 ) may be sending very bearish...

The board of nms Holdings Corporation ( TSE:2162 ) has announced that it will be paying its dividend of ¥20.00 on the...

The board of The 77 Bank, Ltd. ( TSE:8341 ) has announced that it will pay a dividend on the 30th of June, with...

Sharingtechnology, Inc. ( TSE:3989 ) shareholders would be excited to see that the share price has had a great month...

In December 2025, Sumitomo Pharma America presented updated Phase 1/2 clinical data at the 67th American Society of Hematology Annual Meeting in Orlando, highlighting its investigational oral menin inhibitor enzomenib for relapsed or refractory acute leukemia and PIM1 kinase inhibitor nuvisertib for relapsed or refractory myelofibrosis. The promising response rates and favorable safety profiles reported for these two early-stage oncology candidates point to a strengthening hematology...